BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6835220)

  • 41. Morphological transformation, sister chromatid exchange and mutagenesis assay of betel constituents.
    Umezawa K; Fujie S; Sawamura M; Matsushima T; Katoh Y; Tanaka M; Takayama S
    Toxicol Lett; 1981 Apr; 8(1-2):17-22. PubMed ID: 7245236
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antagonization by cycloheximide of ethyl methanesulfonate-induced 6-thioguanine-resistant mutation and sister-chromatid exchanges.
    Sono A; Sakaguchi K
    Mutat Res; 1982 Dec; 106(2):265-76. PubMed ID: 6891437
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The induction of sister chromatid exchanges by anticancer agents in agents in cultured human lymphocytes and a hazard of muta-carcinogenicity in man (author's transl)].
    Misawa S; Tsuji T; Ide T; Sonoda Y; Abe T; Takino T
    Nihon Gan Chiryo Gakkai Shi; 1980 Dec; 15(7):1085-90. PubMed ID: 7229466
    [No Abstract]   [Full Text] [Related]  

  • 44. Sister-chromatid exchange induction by indirect mutagens/carcinogens, aryl hydrocarbon hydroxylase activity and benzo[alpha]pyrene metabolism in cultured human hepatoma cells.
    Abe S; Nemoto N; Sasaki M
    Mutat Res; 1983 Apr; 109(1):83-90. PubMed ID: 6300668
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sister chromatid exchange as a test for mutagenic carcinogens.
    Wolff S
    Ann N Y Acad Sci; 1983; 407():142-53. PubMed ID: 6349471
    [No Abstract]   [Full Text] [Related]  

  • 46. Frequency of sister chromatid exchanges in human lymphocytes cultivated with a human hepatoma cell line as an indicator of the carcinogenic potency of two cyclopenta[a]phenanthrenes.
    Lindahl-Kiessling K; Bhatt TS; Karlberg I; Coombs MM
    Carcinogenesis; 1984 Jan; 5(1):11-4. PubMed ID: 6537803
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mutagenicity of urine and faeces after treatment of rats with known genotoxins.
    Willems MI; de Raat WK
    Carcinogenesis; 1985 Jul; 6(7):967-76. PubMed ID: 3893784
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Photopromotion of sister chromatid exchanges by psoralen derivatives.
    Carter DM; Lyons MF; Windhorst DB
    Arch Dermatol Res; 1982; 272(3-4):239-44. PubMed ID: 7165331
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Viscometric detection of liver DNA fragmentation in rats treated with ten aromatic amines. Discrepancies with results provided by the alkaline elution technique.
    Brambilla G; Carlo P; Finollo R; Ledda A
    Carcinogenesis; 1985 Sep; 6(9):1285-8. PubMed ID: 4028326
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Short-term tests for transplacentally active carcinogens. A comparison of sister-chromatid exchange and the micronucleus test in mouse foetal liver erythroblasts.
    Cole RJ; Cole J; Henderson L; Taylor NA; Arlett CF; Regan T
    Mutat Res; 1983 Feb; 113(1):61-75. PubMed ID: 6298615
    [TBL] [Abstract][Full Text] [Related]  

  • 51. SCE induction by indirect mutagens/carcinogens in metabolically active cultured mammalian cell lines.
    Abe S
    Basic Life Sci; 1984; 29 Pt B():535-45. PubMed ID: 6529414
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of metabolic activation in the sister chromatid exchange-inducing activity of ethyl carbamate (urethane) and vinyl carbamate.
    Csukás I; Gungl E; Antoni F; Vida G; Solymosy F
    Mutat Res; 1981 May; 89(1):75-82. PubMed ID: 7242548
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Induction of sister-chromatid exchanges (SCEs) and chromosomal aberrations by mitomycin C and methyl methanesulfonate in Chinese hamster ovary cells. An evaluation of methodology for detection of SCEs and of persistent DNA lesions towards the frequencies of observed SCEs.
    Natarajan AT; Tates AD; Meijers M; Neuteboom I; de Vogel N
    Mutat Res; 1983 Sep; 121(3-4):211-23. PubMed ID: 6413854
    [No Abstract]   [Full Text] [Related]  

  • 54. Elimination of metabolic co-operation and the induction of sister chromatid exchanges are not properties common to all promoting or co-carcinogenic agents.
    Kinsella AR
    Carcinogenesis; 1982; 3(5):499-503. PubMed ID: 7094211
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Enhancement of benzo(a)pyrene-induced sister chromatid exchanges as a consequence of glutathione depletion in vivo.
    Bayer U; Younes M; Siegers CP
    Toxicol Lett; 1981 Dec; 9(4):339-43. PubMed ID: 6277046
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Actions of amino-beta-carbolines on induction of sister-chromatid exchanges.
    Tohda H; Tada M; Sugawara R; Oikawa A
    Mutat Res; 1983 Feb; 116(2):137-47. PubMed ID: 6828050
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intercalating substances do not induce sister-chromatid exchanges (SCEs) in vivo.
    Speit G
    Mutat Res; 1982; 104(4-5):261-6. PubMed ID: 7110164
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The frequency of sister-chromatid exchanges in human lymphocytes treated with some methylindoles.
    Jansson T; Florin I
    Mutat Res; 1982 Oct; 105(4):271-5. PubMed ID: 7133034
    [No Abstract]   [Full Text] [Related]  

  • 59. Comparison of metabolic systems required to activate pro-mutagens/carcinogens in vitro for sister-chromatid exchange studies.
    Wojciechowski JP; Kaur P; Sabharwal PS
    Mutat Res; 1981 Jan; 88(1):89-97. PubMed ID: 6782474
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of the frequencies of SCEs induced by chemical mutagens in bone-marrow, spleen and spermatogonial cells of mice.
    Palitti F; Tanzarella C; Cozzi R; Ricordy R; Vitagliano E; Fiore M
    Mutat Res; 1982 Feb; 103(2):191-5. PubMed ID: 7057795
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.